Table 8.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Kidney-Pancreas Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 983 100.0% 3,337 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 18 1.8% 71 2.1%
OKT3 1 0.1% 28 0.8%
Thymoglobulin 592 60.2% 1,528 45.8%
Zenapax 17 1.7% 322 9.6%
Simulect 21 2.1% 571 17.1%
Campath 241 24.5% 208 6.2%
Rituximab 1 0.1% 3 0.1%
No Induction Drug Reported 143 14.5% 759 22.7%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.